Correlation Between Arcus Biosciences and Iteos Therapeutics

Can any of the company-specific risk be diversified away by investing in both Arcus Biosciences and Iteos Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arcus Biosciences and Iteos Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Arcus Biosciences and Iteos Therapeutics, you can compare the effects of market volatilities on Arcus Biosciences and Iteos Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arcus Biosciences with a short position of Iteos Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arcus Biosciences and Iteos Therapeutics.

Diversification Opportunities for Arcus Biosciences and Iteos Therapeutics

0.69

Correlation Coefficient

Arcus Biosciences  Iteos Therapeutics

Poor diversification

The 3 months correlation between Arcus and Iteos is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding Arcus Biosciences and Iteos Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Iteos Therapeutics and Arcus Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arcus Biosciences are associated (or correlated) with Iteos Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Iteos Therapeutics has no effect on the direction of Arcus Biosciences i.e., Arcus Biosciences and Iteos Therapeutics go up and down completely randomly.

Pair Corralation between Arcus Biosciences and Iteos Therapeutics

Given the investment horizon of 90 days Arcus Biosciences is expected to under-perform the Iteos Therapeutics. In addition to that, Arcus Biosciences is 1.49 times more volatile than Iteos Therapeutics. It trades about -0.23 of its total potential returns per unit of risk. Iteos Therapeutics is currently generating about -0.04 per unit of volatility. If you would invest  741.00  in Iteos Therapeutics on December 25, 2024 and sell it today you would lose (52.00) from holding Iteos Therapeutics or give up 7.02% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Arcus Biosciences  vs.  Iteos Therapeutics

Arcus Biosciences

Risk-Adjusted Performance

Very Weak

Over the last 90 days Arcus Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Iteos Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Iteos Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Iteos Therapeutics is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Arcus Biosciences and Iteos Therapeutics

The main advantage of trading using opposite Arcus Biosciences and Iteos Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arcus Biosciences position performs unexpectedly, Iteos Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Iteos Therapeutics will offset losses from the drop in Iteos Therapeutics' long position.

The idea behind Arcus Biosciences and Iteos Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.